3-Methyl-1-naphthalen-2-ylbutan-1-amine | 1189819-42-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: 3-Methyl-1-naphthalen-2-ylbutan-1-amine
• CAS: 1189819-42-8
• 化学式: C₁₅H₁₉N
• 分子量: 213.323
• InChiKey: HEKVYVKLZQTKSD-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.1
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-氨基-4,6-二氯-S-三嗪 、 3-Methyl-1-naphthalen-2-ylbutan-1-amine 在 potassium carbonate 作用下， 以 1,4-二氧六环 为溶剂， 生成
  参考文献：
  名称：

  Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitors

  摘要：

  Tryptophan hydroxylase (TPH) is a key enzyme in the synthesis of serotonin. As a neurotransmitter, serotonin plays important physiological roles both peripherally and centrally. Here we describe the discovery of substituted triazines as a novel class of tryptophan hydroxylase inhibitors. This class of TPH inhibitors can selectively reduce serotonin levels in murine intestine after oral administration without affecting levels in the brain. These TPH inhibitors may provide novel treatments for gastrointestinal disorders associated with dysregulation of the serotonergic system, such as chemotherapy-induced emesis and irritable bowel syndrome. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2009.07.005

文献信息

• Substituted 3-(4-(1,3,5-triazin-2-yl)-phenyl)-2-aminopropanoic acids as novel tryptophan hydroxylase inhibitors
  作者：Haihong Jin、Giovanni Cianchetta、Arokiasamy Devasagayaraj、Kunjian Gu、Brett Marinelli、Lakshman Samala、Sheldon Scott、Terry Stouch、Ashok Tunoori、Ying Wang、Yi Zang、Chengmin Zhang、S. David Kimball、Alan J. Main、Zhi-Ming Ding、Weimei Sun、Qi Yang、Xiang-Qing Yu、David R. Powell、Alan Wilson、Qingyun Liu、Zhi-Cai Shi

  DOI：10.1016/j.bmcl.2009.07.005

  日期：2009.9

  Tryptophan hydroxylase (TPH) is a key enzyme in the synthesis of serotonin. As a neurotransmitter, serotonin plays important physiological roles both peripherally and centrally. Here we describe the discovery of substituted triazines as a novel class of tryptophan hydroxylase inhibitors. This class of TPH inhibitors can selectively reduce serotonin levels in murine intestine after oral administration without affecting levels in the brain. These TPH inhibitors may provide novel treatments for gastrointestinal disorders associated with dysregulation of the serotonergic system, such as chemotherapy-induced emesis and irritable bowel syndrome. (C) 2009 Elsevier Ltd. All rights reserved.